BR112013016008A2 - solução oftálmica compreendendo diquafosol, método para a produção da mesma, e método para a inibição da formação de precipitado insolúvel. - Google Patents
solução oftálmica compreendendo diquafosol, método para a produção da mesma, e método para a inibição da formação de precipitado insolúvel.Info
- Publication number
- BR112013016008A2 BR112013016008A2 BR112013016008-0A BR112013016008A BR112013016008A2 BR 112013016008 A2 BR112013016008 A2 BR 112013016008A2 BR 112013016008 A BR112013016008 A BR 112013016008A BR 112013016008 A2 BR112013016008 A2 BR 112013016008A2
- Authority
- BR
- Brazil
- Prior art keywords
- diquafosol
- manufacturing
- same
- precipitation thing
- insoluble precipitation
- Prior art date
Links
- NMLMACJWHPHKGR-NCOIDOBVSA-N P(1),P(4)-bis(uridin-5'-yl) tetraphosphate Chemical compound N1([C@@H]2O[C@@H]([C@H]([C@H]2O)O)COP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@H]([C@@H](O2)N2C(NC(=O)C=C2)=O)O)O)C=CC(=O)NC1=O NMLMACJWHPHKGR-NCOIDOBVSA-N 0.000 title 1
- 229950003529 diquafosol Drugs 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000001556 precipitation Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010291463 | 2010-12-28 | ||
JP2010-291463 | 2010-12-28 | ||
PCT/JP2011/080179 WO2012090994A1 (ja) | 2010-12-28 | 2011-12-27 | ジクアホソル含有点眼液およびその製造方法、不溶性析出物発生の抑制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112013016008A2 true BR112013016008A2 (pt) | 2018-07-10 |
BR112013016008B1 BR112013016008B1 (pt) | 2021-06-29 |
Family
ID=46383087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013016008-0A BR112013016008B1 (pt) | 2010-12-28 | 2011-12-27 | Solução oftálmica compreendendo diquafosol, método para a produção da mesma, e método para a inibição da formação de precipitado insolúvel |
Country Status (16)
Country | Link |
---|---|
US (1) | US20140221306A1 (pt) |
EP (1) | EP2659894A4 (pt) |
JP (1) | JP2012149057A (pt) |
KR (1) | KR20140003493A (pt) |
CN (1) | CN103282039A (pt) |
AU (1) | AU2011350762B2 (pt) |
BR (1) | BR112013016008B1 (pt) |
CA (1) | CA2823148A1 (pt) |
EA (1) | EA027736B1 (pt) |
GE (1) | GEP20166448B (pt) |
MX (1) | MX2013007502A (pt) |
MY (1) | MY161032A (pt) |
SG (2) | SG10201508591UA (pt) |
TW (1) | TW201306844A (pt) |
UA (1) | UA113839C2 (pt) |
WO (1) | WO2012090994A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX353874B (es) * | 2012-03-26 | 2018-02-01 | Santen Pharmaceutical Co Ltd | Gotas para los ojos que contienen diquafosol. |
SG11201705138QA (en) * | 2014-12-25 | 2017-07-28 | Santen Pharmaceutical Co Ltd | Aqueous ophthalmic solution |
RU2742032C2 (ru) | 2015-06-05 | 2021-02-01 | Сантен Фармасьютикал Ко., Лтд. | Терапевтическое средство против сухости глаз, характеризуемое нанесением на глаза пациентов с сухостью глаз, носящих гибкие контактные линзы |
KR20220163519A (ko) * | 2018-02-28 | 2022-12-09 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 및 양이온성 폴리머를 함유하는 안과용 조성물 |
CN108853016A (zh) * | 2018-09-26 | 2018-11-23 | 广州大光制药有限公司 | 一种地夸磷索钠滴眼液及其制备方法 |
WO2020175525A1 (ja) * | 2019-02-27 | 2020-09-03 | 参天製薬株式会社 | ジクアホソルまたはその塩、ビニル系高分子およびセルロース系高分子を含有する眼科用組成物 |
KR20240049646A (ko) * | 2019-08-27 | 2024-04-16 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물 |
JP7230169B2 (ja) * | 2020-12-25 | 2023-02-28 | 参天製薬株式会社 | ジクアホソルまたはその塩、銀塩およびイオン性等張化剤を含有する水性点眼液 |
CN113712910A (zh) * | 2021-08-05 | 2021-11-30 | 广州市桐晖药业有限公司 | 一种滴眼液及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5900407A (en) * | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
PT1012154E (pt) | 1997-07-25 | 2004-08-31 | Inspire Pharmaceuticals Inc | Sais de di(5'-tetrafosfato de uridina), metodo para a sua preparacao, e suas utilizacoes |
JP4003008B2 (ja) * | 2000-05-30 | 2007-11-07 | 参天製薬株式会社 | 角膜上皮伸展促進剤 |
KR100832821B1 (ko) * | 2000-05-30 | 2008-05-28 | 산텐 세이야꾸 가부시키가이샤 | 각막 상피 신장 촉진제 |
JP2003160491A (ja) * | 2001-09-11 | 2003-06-03 | Santen Pharmaceut Co Ltd | ジウリジンリン酸含有点眼液 |
JP4168071B2 (ja) | 2005-12-08 | 2008-10-22 | 興和株式会社 | 点眼用組成物 |
EA026680B1 (ru) * | 2010-09-10 | 2017-05-31 | Сантен Фармасьютикал Ко., Лтд. | Средство для лечения синдрома сухого глаза, характеризующееся комбинированием агониста рецептора p2yи гиалуроновой кислоты или ее соли, способ лечения синдрома сухого глаза и применение агониста рецептора p2yи гиалуроновой кислоты или ее соли |
-
2011
- 2011-12-27 SG SG10201508591UA patent/SG10201508591UA/en unknown
- 2011-12-27 WO PCT/JP2011/080179 patent/WO2012090994A1/ja active Application Filing
- 2011-12-27 EP EP11852288.7A patent/EP2659894A4/en not_active Withdrawn
- 2011-12-27 MY MYPI2013002461A patent/MY161032A/en unknown
- 2011-12-27 SG SG2013050000A patent/SG191389A1/en unknown
- 2011-12-27 TW TW100148759A patent/TW201306844A/zh unknown
- 2011-12-27 CN CN2011800632699A patent/CN103282039A/zh active Pending
- 2011-12-27 MX MX2013007502A patent/MX2013007502A/es unknown
- 2011-12-27 UA UAA201309390A patent/UA113839C2/uk unknown
- 2011-12-27 BR BR112013016008-0A patent/BR112013016008B1/pt not_active IP Right Cessation
- 2011-12-27 KR KR1020137019146A patent/KR20140003493A/ko not_active Application Discontinuation
- 2011-12-27 EA EA201390985A patent/EA027736B1/ru unknown
- 2011-12-27 JP JP2011285977A patent/JP2012149057A/ja not_active Withdrawn
- 2011-12-27 AU AU2011350762A patent/AU2011350762B2/en not_active Ceased
- 2011-12-27 GE GEAP201113176A patent/GEP20166448B/en unknown
- 2011-12-27 CA CA2823148A patent/CA2823148A1/en not_active Abandoned
- 2011-12-27 US US13/976,408 patent/US20140221306A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MX2013007502A (es) | 2013-08-01 |
UA113839C2 (xx) | 2017-03-27 |
GEP20166448B (en) | 2016-03-25 |
CN103282039A (zh) | 2013-09-04 |
CA2823148A1 (en) | 2012-07-05 |
EA201390985A1 (ru) | 2013-11-29 |
SG191389A1 (en) | 2013-07-31 |
EA027736B1 (ru) | 2017-08-31 |
BR112013016008B1 (pt) | 2021-06-29 |
EP2659894A1 (en) | 2013-11-06 |
SG10201508591UA (en) | 2015-11-27 |
WO2012090994A1 (ja) | 2012-07-05 |
AU2011350762A1 (en) | 2013-07-25 |
JP2012149057A (ja) | 2012-08-09 |
AU2011350762B2 (en) | 2017-04-06 |
MY161032A (en) | 2017-04-03 |
US20140221306A1 (en) | 2014-08-07 |
KR20140003493A (ko) | 2014-01-09 |
EP2659894A4 (en) | 2014-12-10 |
TW201306844A (zh) | 2013-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013016008A2 (pt) | solução oftálmica compreendendo diquafosol, método para a produção da mesma, e método para a inibição da formação de precipitado insolúvel. | |
BR112013015810A2 (pt) | método de fabricação de embalagens. | |
EP3027787A4 (en) | Organic disulfide based corrosion inhibitors | |
BR112012015988A2 (pt) | método | |
IL235690A0 (en) | A method and system for producing an irrigation pipe | |
BR112015009583A2 (pt) | instalação de distribuição de gás. | |
GB201600717D0 (en) | Platform for tidal turbines | |
BR112013009024A2 (pt) | método | |
BR112012023891A2 (pt) | método | |
EP2899111A4 (en) | PROCESS FOR ASSEMBLING A FLOATING WIND POWER GENERATOR AND FLOATING WIND POWER GENERATOR | |
GB2495884B (en) | A method of increasing the effect of an activated-potentiated form of an antibody | |
GB201320041D0 (en) | Offshore foundation | |
IT1398747B1 (it) | Oscillatore. | |
IT1398492B1 (it) | Impianto orc cogenerativo | |
EP2864575A4 (en) | DEAD UVRE SYSTEM | |
BR112013013894A2 (pt) | método para fabricação de um tri-halossilano | |
BR112013015580A2 (pt) | método de radioestabilização | |
BR112012033000A2 (pt) | método | |
GB201418909D0 (en) | Tidal turbine system | |
FI20125268A (fi) | Putkiliitos ja menetelmä putkiliitoksen muodostamiseksi | |
FR2969129B1 (fr) | Opercule thermoscellable a languette, et procede de fabrication dudit opercule | |
FR2956437B1 (fr) | Procede de prevention contre le pompage d'un turbocompresseur | |
IT1401345B1 (it) | Bomboletta. | |
ITVR20120139A1 (it) | Impianto per la produzione di tubi flessibili. | |
BRPI1011268A2 (pt) | tubulação, e, método para a fabricação de uma tubulação. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B04C | Request for examination: application reinstated [chapter 4.3 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/12/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2755 DE 24-10-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |